6 research outputs found

    A multicenter study of invasive fungal infections in patients with childhood-onset systemic lupus erythematosus

    No full text
    To study the prevalence, risk factors, and mortality of invasive fungal infections (IFI) in patients with childhood-onset systemic lupus erythematosus (cSLE). A retrospective multicenter cohort study was performed in 852 patients with cSLE from 10 pediatric rheumatology services. An investigator meeting was held and all participants received database training. IFI were diagnosed according to the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group Consensus Group criteria (proven, probable, and possible). Also evaluated were demographic, clinical, and laboratory data, and disease activity [SLE Disease Activity Index 2000 (SLEDAI-2K)], cumulative damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index), treatment, and outcomes. IFI were observed in 33/852 patients (3.9%) with cSLE. Proven IFI was diagnosed in 22 patients with cSLE, probable IFI in 5, and possible IFI in 6. Types of IFI were candidiasis (20), aspergillosis (9), cryptococcosis (2), and 1 each disseminated histoplasmosis and paracoccidioidomycosis. The median of disease duration was lower (1.0 vs 4.7 yrs, p < 0.0001) with a higher current SLEDAI-2K [19.5 (0–44) vs 2 (0–45), p < 0.0001] and current prednisone (PRED) dose [50 (10–60) vs 10 (2–90) mg/day, p < 0.0001] in patients with IFI compared with those without IFI. The frequency of death was higher in the former group (51% vs 6%, p < 0.0001). Logistic regression analysis revealed that SLEDAI-2K (OR 1.108, 95% CI 1.057–1.163, p < 0.0001), current PRED dose (OR 1.046, 95% CI 1.021–1.071, p < 0.0001), and disease duration (OR 0.984, 95% CI 0.969–0.998, p = 0.030) were independent risk factors for IFI (R2 Nagelkerke 0.425). To our knowledge, this is the first study to characterize IFI in patients with cSLE. We identified that disease activity and current glucocorticoid use were the main risk factors for these life-threatening infections, mainly in the first years of disease course, with a high rate of fatal outcome421222962303CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ301805/2013-0; 305068/2014-8; 302724/2011-7Supported by grants from Conselho Nacional de Desenvolvimento CientĂ­fico e TecnolĂłgico (CNPq 301805/2013-0 to RMRP, 305068/2014-8 to EB, and 302724/2011-7 to CAS), Federico Foundation (to RMRP, EB, and CAS), and by NĂșcleo de Apoio Ă  Pesquisa “SaĂșde da Criança e do Adolescente” da USP (NAP-CriAd) to CA

    Acompanhamento de obra : construção de um edifício multifamiliar

    Get PDF
    Relatório de estågio para obtenção do grau de mestre em Engenharia CivilO Trabalho Final de Mestrado para obtenção do grau de Mestre em Engenharia Civil na årea de especialização de edificaçÔes, no Instituto Superior de Engenharia de Lisboa, serå elaborado sob a forma de relatório de estågio. Durante o período de estågio foi acompanhada a construção de um edifício para habitação coletiva localizado na urbanização Malvarosa, cidade de Alverca. As atividades desenvolvidas em obra e que coincidiram com o período de estågio são essencialmente a montagem de estaleiro, escavação, execução de muros de contenção, ancoragens e execução da estrutura do edifício em betão armado. O relatório de estågio além de caracterizar o empreendimento farå uma abordagem aos trabalhos desenvolvidos e relacionarå estes trabalhos em termos de produção, com o planeamento e o controlo de custos, realçando a importùncia destes elementos para uma correta gestão de obra.The Master Final Work to obtain a Master's Degree in Civil Engineering in Buildings Branch, at Instituto Superior de Engenharia de Lisboa, will be developed in the form of an internship report. During the internship period, it was followed the construction of a building for collective housing located in the urbanization Malvarosa, city of Alverca. The activities carried out on site and which coincided with the period of the stage are essentially the construction site, excavation, execution of retaining walls, anchorages and execution of the structure of the building in reinforced concrete. The internship report, besides characterizing the project, will take an approach to the work developed and will relate these works in terms of production, planning and cost control, emphasizing the importance of these elements for a correct work management.N/

    Pancreatitis subtypes survey in 852 childhood-onset systemic lupus erythematosus patients: a multicenter cohort

    No full text
    Pancreatitis is a rare and a life-threatening SLE manifestation in childhood-onset systemic lupus erythematosus (c-SLE). The objective of this study was to systematically classify pancreatitis in c-SLE according to the International Study Group of Pediatric Pancreatitis (INSPPIRE) and determine the overall prevalence, clinical features, laboratory and first episode outcomes. A multicenter cohort study in 10 Pediatric Rheumatology centers, including 852 cSLE patients. Pancreatitis was diagnosed in 22/852 (2.6%) cSLE patients. It was classified as acute pancreatitis in 20 (91%), acute recurrent pancreatitis in 2 (9%) and none of them had chronic pancreatitis. None of them had gallstones, traumatic pancreatitis or reported alcohol/tobacco use. The comparison of patients with pancreatitis (first episode) and without this complication revealed a shorter disease duration [1(0-10) vs. 4(0-23) years, p < 0.0001] and higher median of SLEDAI-2K [21(0-41) vs. 2(0-45), p < 0.0001]. The frequencies of fever (p < 0.0001), weight loss (p < 0.0001), serositis (p < 0.0001), nephritis (p < 0.0001), arterial hypertension (p < 0.0001), acute renal failure (p < 0.0001), macrophage activation syndrome (p < 0.0001) and death (p = 0.001) were also higher in patients with pancreatitis. The frequencies of intravenous methylprednisolone use (p < 0.0001) and the median of prednisone dose [55(15-60) vs. 11(1-90)mg/day, p < 0.0001] were significantly higher in patients with pancreatitis. Of note, the two patients with acute recurrent pancreatitis had two episodes, with pain-free interval of 1 and 4 years. This was the first study characterizing pancreatitis using the INSPPIRE standardized definitions in patients with cSLE showing that the predominant form is acute pancreatitis seen in association with glucocorticoid treatment and active severe disease
    corecore